Cite
In Silico Mixed Ligand/Structure-Based Design of New CDK-1/PARP-1 Dual Inhibitors as Anti-Breast Cancer Agents.
MLA
Bono, Alessia, et al. “In Silico Mixed Ligand/Structure-Based Design of New CDK-1/PARP-1 Dual Inhibitors as Anti-Breast Cancer Agents.” International Journal of Molecular Sciences, vol. 24, no. 18, Sept. 2023. EBSCOhost, https://doi.org/10.3390/ijms241813769.
APA
Bono, A., La Monica, G., Alamia, F., Mingoia, F., Gentile, C., Peri, D., Lauria, A., & Martorana, A. (2023). In Silico Mixed Ligand/Structure-Based Design of New CDK-1/PARP-1 Dual Inhibitors as Anti-Breast Cancer Agents. International Journal of Molecular Sciences, 24(18). https://doi.org/10.3390/ijms241813769
Chicago
Bono, Alessia, Gabriele La Monica, Federica Alamia, Francesco Mingoia, Carla Gentile, Daniele Peri, Antonino Lauria, and Annamaria Martorana. 2023. “In Silico Mixed Ligand/Structure-Based Design of New CDK-1/PARP-1 Dual Inhibitors as Anti-Breast Cancer Agents.” International Journal of Molecular Sciences 24 (18). doi:10.3390/ijms241813769.